{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:43:31Z","timestamp":1783043011662,"version":"3.54.6"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2621-M006-007"],"award-info":[{"award-number":["109-2621-M006-007"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2314-B-006-032"],"award-info":[{"award-number":["MOST 105-2314-B-006-032"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2627-M-006-010"],"award-info":[{"award-number":["110-2627-M-006-010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2627-M-006-001"],"award-info":[{"award-number":["108-2627-M-006-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106- 2627-M-006-015"],"award-info":[{"award-number":["106- 2627-M-006-015"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2627-M-006-003"],"award-info":[{"award-number":["111-2627-M-006-003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2627-M-006-007"],"award-info":[{"award-number":["107-2627-M-006-007"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2627-M-006-002"],"award-info":[{"award-number":["NSTC 112-2627-M-006-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jfma.2024.05.011","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T08:59:29Z","timestamp":1716195569000},"page":"S234-S241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S3","title":["Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocation"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-4500","authenticated-orcid":false,"given":"Jung-Der","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8310","authenticated-orcid":false,"given":"Wu-Wei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4120-0394","authenticated-orcid":false,"given":"Szu-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5807-7583","authenticated-orcid":false,"given":"Jing-Shiang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2024.05.011_bib1","series-title":"Delivering quality health services: a global imperative for universal health coverage","year":"2018"},{"key":"10.1016\/j.jfma.2024.05.011_bib2","unstructured":"The Economics of Healthcare. Accessed 2023\/08\/05. doi: https:\/\/scholar.harvard.edu\/sites\/scholar.harvard.edu\/files\/mankiw\/files\/economics_of_healthcare.pdf."},{"key":"10.1016\/j.jfma.2024.05.011_bib3","series-title":"Redefining health care: creating value-based competition on results","author":"Porter","year":"2006"},{"issue":"14","key":"10.1016\/j.jfma.2024.05.011_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/jama.2017.1964","article-title":"Vital directions for health and health care: priorities from a national academy of medicine initiative","volume":"317","author":"Dzau","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2024.05.011_bib5","series-title":"reportHarnessing technology for the long-term sustainability of the UK's healthcare system","year":"2021"},{"key":"10.1016\/j.jfma.2024.05.011_bib6","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2015"},{"issue":"15","key":"10.1016\/j.jfma.2024.05.011_bib7","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the panel on cost-effectiveness in health and medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jfma.2024.05.011_bib8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2024.05.011_bib9","author":"Bertram"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.011_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231413","article-title":"Comparative effectiveness and cost-effectiveness of three first-line EGFR-tyrosine kinase inhibitors: analysis of real-world data in a tertiary hospital in Taiwan","volume":"15","author":"Yang","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Eff Resour Allocation"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.011_bib12","first-page":"673","article-title":"Methods for the economic evaluation of health care interventions for priority setting in the health system: an update from WHO CHOICE","volume":"10","author":"Bertram","year":"2021","journal-title":"Int J Health Pol Manag"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12962-020-00256-2","article-title":"QALY league table of Iran: a practical method for better resource allocation","volume":"19","author":"Hashempour","year":"2021","journal-title":"Cost Eff Resour Allocation"},{"key":"10.1016\/j.jfma.2024.05.011_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.831254","article-title":"Comprehensive league table of cost-utility ratios: a systematic review of cost-effectiveness evidence for health policy decisions in India","volume":"10","author":"Shah","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.jfma.2024.05.011_bib15","unstructured":"Global health estimates: Leading causes of DALYs. Geneva, Switzerland."},{"issue":"7","key":"10.1016\/j.jfma.2024.05.011_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMp0708558","article-title":"Does preventive care save money?","volume":"358","author":"Cohen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2024.05.011_bib17","series-title":"Registry for catastrophic illness patients","year":"2021"},{"key":"10.1016\/j.jfma.2024.05.011_bib18","series-title":"National health insurance act","year":"1994"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.011_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0266462319000011","article-title":"Outcomes and impacts of 10-year HTA implementation in Taiwan","volume":"35","author":"Kao","year":"2019","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jfma.2024.05.011_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1097-0258(19960115)15:1<93::AID-SIM155>3.0.CO;2-2","article-title":"Estimation of expected quality adjusted survival by cross-sectional survey","volume":"15","author":"Hwang","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.jfma.2024.05.011_bib21","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/(SICI)1097-0258(19990715)18:13<1627::AID-SIM159>3.0.CO;2-D","article-title":"Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies","volume":"18","author":"Hwang","year":"1999","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.011_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hcl141","article-title":"Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy","volume":"100","author":"Fang","year":"2007","journal-title":"QJM"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.011_bib23","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1002\/hec.3512","article-title":"Estimating lifetime medical costs from censored claims data","volume":"26","author":"Hwang","year":"2017","journal-title":"Health Econ"},{"key":"10.1016\/j.jfma.2024.05.011_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/CLEP.S155601","article-title":"Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan","volume":"10","author":"Wu","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.jfma.2024.05.011_bib25","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jfma.2021.04.023","article-title":"QALYs and medical costs saved from prevention of a cancer: analysis of nation-wide real-world data of Taiwan with lifetime horizon","volume":"120","author":"Lai","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2024.05.011_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2017.04.001","article-title":"Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan","volume":"108","author":"Yang","year":"2017","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.011_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jfma.2021.06.013","article-title":"Cost-effectiveness evaluation of mammography screening program in Taiwan: adjusting different distributions of age and calendar year for real world data","volume":"121","author":"Lin","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2024.05.011_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.oraloncology.2018.12.011","article-title":"Cost-effectiveness analysis of the oral cancer screening program in Taiwan","volume":"89","author":"Huang","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jfma.2024.05.011_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.drugalcdep.2019.05.003","article-title":"Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: evidence from real world data","volume":"201","author":"Chang","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84853-y","article-title":"Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction","volume":"11","author":"Liao","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.011_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14680","article-title":"Optimal intervals of ultrasonography screening for early diagnosis of hepatocellular carcinoma in Taiwan","volume":"4","author":"Kuo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jfma.2024.05.011_bib32","series-title":"iSQoL2 package for windows [webpage on the internet]","year":"2017"},{"issue":"11","key":"10.1016\/j.jfma.2024.05.011_bib33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jfma.2012.12.015","article-title":"Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan","volume":"112","author":"Lee","year":"2013","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.011_bib34","first-page":"342","article-title":"Development and verification of validity and reliability of the WHOQOL-BREF Taiwan Version","volume":"101","author":"Yao","year":"2002","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2024.05.011_bib35","series-title":"National health interview survey in Taiwan","year":"2013"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.011_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/STROKEAHA.109.573543","article-title":"Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jfma.2024.05.011_bib37","article-title":"Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.011_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3747\/pdi.2012.00081","article-title":"Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan","volume":"33","author":"Kao","year":"2013","journal-title":"Perit Dial Int"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.011_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044043","article-title":"Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan","volume":"7","author":"Hung","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.011_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/injuryprev-2020-043943","article-title":"Savings of loss-of-life expectancy and lifetime medical costs from prevention of spinal cord injuries: analysis of nationwide data followed for 17 years","volume":"27","author":"Lien","year":"2021","journal-title":"Inj Prev"},{"issue":"1 Pt 1","key":"10.1016\/j.jfma.2024.05.011_bib41","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jfma.2021.02.008","article-title":"Increasing burden of major trauma in elderly adults during 2003-2015: analysis of real-world data from Taiwan","volume":"121","author":"Lee","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.011_bib42","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.41597","article-title":"Lifetime risks, life expectancy, and health care expenditures for rheumatoid arthritis: a nationwide cohort followed up from 2003 to 2016","volume":"73","author":"Chiu","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1\u20133","key":"10.1016\/j.jfma.2024.05.011_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2016.01.033","article-title":"Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan","volume":"171","author":"Leng","year":"2016","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-181060","article-title":"Estimating life expectancy and lifetime healthcare costs for alzheimer's disease in Taiwan: does the age of disease onset matter?","volume":"73","author":"Yeh","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.011_bib45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jval.2021.03.008","article-title":"Comparison of parametric survival extrapolation approaches incorporating general population mortality for adequate health technology assessment of new oncology drugs","volume":"24","author":"van Oostrum","year":"2021","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jfma.2024.05.011_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1017\/S1474747220000050","article-title":"Getting life expectancy estimates right for pension policy: period versus cohort approach","volume":"20","author":"Ayuso","year":"2020","journal-title":"J Pension Econ Finance"},{"issue":"1 Pt 2","key":"10.1016\/j.jfma.2024.05.011_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jfma.2018.03.018","article-title":"Psychometric evaluation of the WHOQOL-BREF, Taiwan version, across five kinds of Taiwanese cancer survivors: rasch analysis and confirmatory factor analysis","volume":"118","author":"Lin","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2024.05.011_bib48","doi-asserted-by":"crossref","DOI":"10.1023\/B:QURE.0000015299.45623.38","article-title":"Integrating health profile with survival for quality of life","volume":"13","author":"Hwang","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jfma.2024.05.011_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1758834018755072","article-title":"Dynamic changes in quality of life after three first-line therapies for EGFR mutation-positive advanced non-small-cell lung cancer","volume":"10","author":"Yang","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"9","key":"10.1016\/j.jfma.2024.05.011_bib50","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1377\/hlthaff.2021.00343","article-title":"Controversy over using quality-adjusted life-years in cost-effectiveness analyses: a systematic literature review","volume":"40","author":"Rand","year":"2021","journal-title":"Health Aff"},{"key":"10.1016\/j.jfma.2024.05.011_bib51","series-title":"Hospice palliative care act","year":"2013"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.011_bib52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-6296(88)90030-6","article-title":"A QALY is a QALY is a QALY \u2014 or is it?","volume":"7","author":"Weinstein","year":"1988","journal-title":"J Health Econ"},{"issue":"6","key":"10.1016\/j.jfma.2024.05.011_bib53","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Pichon-Riviere","year":"2023","journal-title":"Lancet Global Health"},{"issue":"3","key":"10.1016\/j.jfma.2024.05.011_bib54","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib55","article-title":"Considering lead-time bias in evaluating the effectiveness of lung cancer screening with real-world data","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13023-020-1332-x","article-title":"A roadmap to using historical controls in clinical trials - by drug information association adaptive design scientific working group (DIA-ADSWG)","volume":"15","author":"Ghadessi","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"10.1016\/j.jfma.2024.05.011_bib57","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0272989X231168618","article-title":"A systematic review of methods to incorporate external evidence into trial-based survival extrapolations for health technology assessment","volume":"43","author":"Bullement","year":"2023","journal-title":"Med Decis Making"},{"issue":"14","key":"10.1016\/j.jfma.2024.05.011_bib58","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Global Cardiovascular Risk","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jfma.2024.05.011_bib59","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2023.0015","article-title":"Association of cardiovascular health with life expectancy free of cardiovascular disease, diabetes, cancer, and dementia in UK adults","volume":"183","author":"Wang","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jfma.2024.05.011_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13561-024-00480-z","article-title":"Estimation of lifetime productivity loss from patients with chronic diseases: methods and empirical evidence of end-stage kidney disease from Taiwan","volume":"14","author":"Wang","year":"2024","journal-title":"Health Econ Rev"},{"key":"10.1016\/j.jfma.2024.05.011_bib61","article-title":"Losses of lifetime employment duration and productivity for patients with different subtypes and stages of lung cancer","author":"Yang","year":"2023","journal-title":"Eur J Health Econ"},{"issue":"10","key":"10.1016\/j.jfma.2024.05.011_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075605","article-title":"Estimation of the long-term care needs of stroke patients by integrating functional disability and survival","volume":"8","author":"Hung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jfma.2024.05.011_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MLR.0000000000000010","article-title":"Estimation of physical functional disabilities and long-term care needs for patients under maintenance hemodialysis","volume":"52","author":"Hung","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.jfma.2024.05.011_bib64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eurpsy.2018.07.009","article-title":"Estimate dynamic changes of dysfunction and lifelong spent for psychiatric care needs in patients with schizophrenia","volume":"54","author":"Su","year":"2018","journal-title":"Eur Psychiatr"},{"key":"10.1016\/j.jfma.2024.05.011_bib65","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2305709","article-title":"Reducing health care's climate impact \u2013 mission critical or extra credit?","author":"Rabin","year":"2023","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462400247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966462400247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:06:48Z","timestamp":1778558808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966462400247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":65,"alternative-id":["S092966462400247X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2024.05.011","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating Taiwan's QALY league table for catastrophic illnesses: Providing real-world evidence to integrate prevention with treatment for resources allocation","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2024.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}